Treatment with 7% and 10% CO 2 enhanced expression of IL-1β,TNF-α,and IL-6 in hypoxic cultures of human whole blood

Abstract

Objective

This study investigated whether hypercapnia influenced the inflammatory response of hypoxic blood.

Methods

Human whole blood was cultured with 0.2% oxygen (O₂) and treated with 5%, 7%, or 10% carbon dioxide (CO₂). Interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and IL-6 were evaluated in whole blood cultures. Reactive oxygen species (ROS) production and expression levels of caspase-1 and IL-1β were evaluated in THP-1 monocytic cells.

Results

IL-1β, TNF-α, and IL-6 levels were higher in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group. The hypoxia + 10% CO₂ group had the highest IL-1β, TNF-α, and IL-6 levels, compared with the hypoxia + 7% CO₂ and hypoxia + 5% CO₂ groups. Expression levels of IL-1β, TNF-α, and IL-6 were significantly negatively correlated with pH levels in the cell culture medium. Treatment with 7% and 10% CO₂ increased the production of ROS and the expression of caspase-1 and IL-1β in hypoxia-activated THP-1 cells.

Conclusions

High levels of CO₂ treatment increased expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures. High levels of CO₂-induced ROS overproduction and NLRP3 inflammasome activation in monocytes may comprise a target to mitigate the inflammatory response of hypoxic blood.

Keywords

Hypercapnia hypoxemia acute respiratory distress syndrome inflammation caspase 1 reactive oxygen species monocytes interleukin-6 tumor necrosis factor-alpha interleukin-1

Introduction

Refractory hypoxemia is the main clinical manifestation of acute respiratory distress syndrome (ARDS).^1,2 Lower tidal ventilation is available for routine clinical application, which enables alleviation of hypoxemia, as well as avoidance of ventilator-induced lung injury.^3,4 This ventilation strategy inevitably leads to hypercapnia—elevated levels of carbon dioxide (CO₂) in the blood.^5,6 A lower tidal ventilation strategy exerts some beneficial effects on respiratory systems, which can reduce pulmonary morbidity for patients with ARDS.^5,7,8 However, hypercapnia is a non-physiological state for the human body; thus far, it remains controversial whether hypercapnia is detrimental or protective for patients with ARDS.^9,10

As the main clinical symptom of ARDS, hypoxemia can trigger secretion of inflammatory cytokines (e.g., TNF-α, IL-1β, and IL-6) in the blood.¹¹ In addition, the blood-mediated inflammatory response can cause injury to critical organs.¹² There are close links between the degree of hypoxemia and mortality in patients with ARDS, as well as between the duration of hypoxemia and mortality in those patients.¹³ For patients with both hypoxemia and hypercapnia, the molecular mechanism of the inflammatory response may be complex. Hypercapnia has been reported to attenuate endotoxin-induced inflammation by inhibiting activation of nuclear factor-κB.^14,15 However, under hypoxic conditions, there may be differences in the underlying mechanism whereby hypercapnia exerts its effects on the blood-mediated inflammatory response.

Our previous study revealed that hypercapnia-induced activation of the NLR family, pyrin domain-containing 3 protein (NLRP3) inflammasome could upregulate the expression of IL-1β in hypoxia-activated microglia.¹⁶ Moreover, IL-1β has been shown to promote the central nervous system cascade inflammatory response.^17,18 It is unknown whether hypercapnia exerts any effects on the peripheral inflammation of hypoxic blood. Here, we hypothesized that hypercapnia might enhance the inflammation of hypoxic blood, specifically by increasing IL-1β, TNF-α, and IL-6 expression in hypoxic blood.

Materials and methods

Ethics and consent

The study was approved by the Research Ethics Committee of Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (Approval no. GDREC2018424H(R1)). All participants provided written informed consent for inclusion in the study.

Human whole blood cultures and treatment

Whole blood was collected from six healthy male volunteers (mean age, 38 ± 9.9 years). None of the volunteers had a history of hematologic disorders, transplantations, cancers, autoimmune diseases, infection, or immunosuppressive drug use. Whole blood was cultured as reported previously.¹⁴ Briefly, 2 mL of whole blood were collected from each volunteer. Whole blood samples were cultured with 18 mL Roswell Park Memorial Institute (RPMI)-1640 medium (Invitrogen, Carlsbad, CA, USA; cat. no. R2405) supplemented with 10% human serum (Gemini Bio-Products, Calabasas, CA, USA; cat. no. H91S001) and 1% penicillin-streptomycin solution (Roche, Basel, Switzerland; cat. no. 11074440001) at 37°C in a humidified incubator with 5% CO₂/95% air.

Blood samples were randomly divided into four groups: control (exposed to 20% O₂ + 5% CO₂ for 24 hours), hypoxia + 5% CO₂ (exposed to 5% CO₂ + 0.2% O₂ for 24 hours), hypoxia + 7% CO₂ (exposed to 7% CO₂ + 0.2% O₂ for 24 hours), and hypoxia + 10% CO₂ (exposed to 10% CO₂ + 0.2% O₂ for 24 hours). The partial pressure of oxygen (PO₂), partial pressure of carbon dioxide (PCO₂), and pH of the medium were measured at 24 hours (n = 6 per group) using a Blood Gas/Electrolyte Analyzer (Model 5700, Instrumentation Laboratory, San Diego, CA, USA).

Evaluation of IL-1β, TNF-α, and IL-6 expression levels in whole blood cultures

IL-1β, TNF-α, and IL-6 levels were evaluated using enzyme-linked immunosorbent assay kits (all from Abcam, Cambridge, MA, USA; IL-1β: cat. no. ab46052; TNF-α: cat. no. ab181421; IL-6: cat. no. ab178013), in accordance with the manufacturers’ instructions. Briefly, samples and standards were added to plate wells that had been coated with horseradish peroxidase-labeled anti-IL-1β, anti-TNF-α, and anti-IL-6 antibodies. A 3,3',5,5'-tetramethylbenzidine substrate solution was then added to the wells. Subsequently, stop buffer was added, and the optical density at 450 nm was measured using a spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Concentrations of IL-1β, TNF-α, and IL-6 in the samples were determined by comparing the optical density of the samples with the optical density of the standard curve. This experiment was repeated six times.

Human THP-1 cells: culture and treatment

Monocytes are reportedly the main cellular source of proinflammatory cytokines.^19,20 Thus, the THP-1 human monocytic cell line was used in the present study; these cells were purchased form American Type Culture Collection (Manassas, VA, USA). THP-1 cells were cultured with RPMI-1640 medium supplemented with 10% fetal bovine serum (Invitrogen; cat. no. 16140071) and 1% penicillin-streptomycin solution at 37°C in a 5% CO₂ incubator. THP-1 monocytes were cultured in six-well plates (1 × 10⁶ cells/mL, 2 mL) for 48 hours in the presence of 100 nM phorbol 12-myristate 13-acetate,²¹ which stimulated differentiation into macrophages. Macrophages were randomly divided into six groups: control (exposed to 5% CO₂ + 20% O₂), hypoxia + 5% CO₂ (exposed to 5% CO₂ + 0.2% O₂), hypoxia + 7% CO₂ (exposed to 7% CO₂ + 0.2% O₂), hypoxia + 10% CO₂ (exposed to 10% CO₂ + 0.2% O₂), hypoxia + 10% CO₂ + N-acetyl-L-cysteine (NAC), and hypoxia + 10% CO₂ + Z-YVAD-FMK. Cells in the hypoxia + 10% CO₂ + NAC and hypoxia + 10% CO₂ + Z-YVAD-FMK groups were respectively treated with an ROS scavenger, 25 mM NAC^22–24 (MedChemExpress, Monmouth, NJ, USA; cat. no. HY-B0215), and a pan-caspase inhibitor, 10 μM Z-YVAD-FMK^25,26 (ApexBio, Boston, MA, USA; cat. no. A8955), for 30 minutes before exposure to 10% CO₂ + 0.2% O₂.

Measurement of reactive oxygen species (ROS)

ROS production in macrophages was evaluated using a ROS assay kit (BestBio, Shanghai, China; cat. no. BB-4705-2), in accordance with the manufacturers’ instructions. Briefly, DCFH-DA was diluted (1:1500) with RPMI-1640 medium without fetal bovine serum. Coverslips with adherent cells were cultured with RPMI-1640 medium supplemented with 10% fetal bovine serum. The medium was changed to diluted DCFH-DA (2 mL/well) after treatment with different concentrations of CO₂ and O₂; cells were incubated in this medium for 20 minutes at 37°C with 5% CO₂. Coverslips were then washed using RPMI-1640 medium without fetal bovine serum. Finally, coverslips were mounted with a fluorescent mounting medium and detected using a fluorescence microscope (Olympus DP73 Microscope, Olympus, Tokyo, Japan). This experiment was repeated four times.

Western blotting

In accordance with the manufacturer’s instructions, total protein extracts from cells were prepared using a Total Protein Extraction Kit (BestBio Science, Shanghai, China; cat. no. BB-3101-100T). Total protein concentrations were determined using a Bioepitope Bicinchoninic Acid Protein Assay Kit (Bioworld Technology Co., Ltd, Nanjing, China; cat. no. 23227). Protein samples were separated on polyacrylamide-SDS gels and transferred onto nitrocellulose membranes. After membranes had been blocked with 5% non-fat dry milk in Tris-buffered saline for 1 hour, they were incubated overnight at 4°C with the following primary antibodies: anti-caspase-1 (rabbit monoclonal IgG, 1:1000, Abcam; cat. no. ab207802) and anti-IL-1β (rabbit polyclonal IgG, 0.2 μg/mL, Abcam; cat. no. ab9722). After membranes had been washed three times in Tris-buffered saline with Tween-20, they were incubated with a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:1000; Cell Signaling Technology, Danvers, MA, USA; cat. no. #7074) for 45 minutes at room temperature. Immunoblots were developed using an enhanced chemiluminescence detection system (ImageQuant LAS 500, GE Healthcare Bio-Sciences AB, Uppsala, Sweden). Band intensities were quantified using ImageJ 1.39u software (National Institutes of Health, Bethesda, MD, USA). This experiment was repeated four times.

Statistical analysis

Statistical analysis was performed using SPSS Statistics, version 19.0 (IBM Corp., Armonk, NY, USA). All values are expressed as means ± standard deviations. One-way analysis of variance was used to analyze univariate-factor measurement data. Correlations between pH and each of the following factors were analyzed with Spearman’s rank correlation coefficient: IL-1β, TNF-α, and IL-6. Differences were considered statistically significant when P < 0.05.

Results

PO₂, PCO₂, and pH levels in whole blood culture medium

Compared with the control group, 0.2% O₂ treatment reduced PO₂ levels in the medium of the hypoxia + 5% CO₂ (P < 0.01), hypoxia + 7% CO₂ (P < 0.01), and hypoxia + 10% CO₂ groups (P < 0.01). PO₂ levels did not significantly differ among 0.2% O₂-treated groups (Figure 1a; Table 1); PCO₂ levels also did not significantly differ between the hypoxia + 5% CO₂ and control groups. PCO₂ levels were much higher in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group (P < 0.01). Notably, the hypoxia + 10% CO₂ group had the highest PCO₂ levels, compared with the hypoxia + 7% CO₂ (P < 0.01) and hypoxia + 5% CO₂ groups (P < 0.01) (Figure 1b; Table 1). pH levels were much lower in the hypoxia + 5% CO₂ group than in the control group (P < 0.01); pH levels were also much lower in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group (P < 0.01). Notably, the hypoxia + 10% group had the lowest pH levels, compared with the hypoxia + 7% CO₂ (P < 0.01) and hypoxia + 5% CO₂ groups (P < 0.01) (Figure 1c; Table 1).

Figure 1.

PO₂ (a), PCO₂ (b), and pH (c) levels in whole blood culture medium at 24 hours (n = 6 per group). ^**P < 0.01. Exposures were as follows: control (20% O₂ + 5% CO₂), hypoxia + 5% CO₂ (5% CO₂ + 0.2% O₂), hypoxia + 7% CO₂ (7% CO₂ + 0.2% O₂), and hypoxia + 10% CO₂ (10% CO₂ + 0.2% O₂).

Table 1.

PO₂, PCO₂, and pH levels in whole blood culture medium (n = 6 per group)

	PO₂ (mmHg)	PCO₂ (mmHg)	pH
Control	158.50 ± 2.17	37.83 ± 2.32	7.43 ± 0.02
Hypoxia + 5% CO₂	59.17 ± 2.14^*	38.00 ± 2.37	7.34 ± 0.03
Hypoxia + 7% CO₂	59.67 ± 1.63^*	55.67 ± 2.73^{* #}	7.27 ± 0.01^{* #}
Hypoxia + 10% CO₂	60.00 ± 2.37^*	66.33 ± 2.50^{* #}	7.22 ± 0.02^{* #}

Compared with the control group: ^*P < 0.01; compared with the hypoxia + 5% CO₂ group: ^#P < 0.01.

Abbreviations: PCO₂, partial pressure of carbon dioxide; PO₂, partial pressure of artery blood oxygen; pH, potential of hydrogen.

Higher levels of CO₂ treatment increased IL-1β, TNF-α, and IL-6 expression levels in hypoxic whole blood cultures

IL-1β levels were much higher in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group (P < 0.05); the hypoxia + 10% CO₂ group had the highest IL-1β levels, compared with the hypoxia + 7% CO₂ (P < 0.05) and hypoxia + 5% CO₂ groups (P < 0.01) (Figure 2a; Table 2). TNF-α levels were much higher in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group (P < 0.05); the hypoxia + 10% CO₂ group had the highest TNF-α levels, compared with the hypoxia + 7% CO₂ (P < 0.05) and hypoxia + 5% CO₂ groups (P < 0.01) (Figure 2b; Table 2). IL-6 levels were much higher in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group (P < 0.05); the hypoxia + 10% CO₂ group had the highest IL-6 levels, compared with the hypoxia + 7% CO₂ (P < 0.05) and hypoxia + 5% CO₂ groups (P < 0.01) (Figure 2c; Table 2).

Figure 2.

Higher levels of CO₂ treatment increased (a) IL-1β, (b) TNF-α, and (c) IL-6 expression in hypoxic whole blood cultures (n = 6 per group; evaluated by enzyme-linked immunosorbent assay). ^*P < 0.05, ^**P < 0.01. Exposures were as follows: control (20% O₂ + 5% CO₂), hypoxia + 5% CO₂ (5% CO₂ + 0.2% O₂), hypoxia + 7% CO₂ (7% CO₂ + 0.2% O₂), and hypoxia + 10% CO₂ (10% CO₂ + 0.2% O₂).

Table 2.

Effects of CO₂ treatment on expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures (n = 6 per group)

	IL-1β (pg/mL)	TNF-α (pg/mL)	IL-6 (pg/mL)
Hypoxia + 5% CO₂	642.33 ± 196.58	431.50 ± 188.32	3829.33 ± 1257.81
Hypoxia + 7% CO₂	1082.67 ± 368.24^$	822.17 ± 266.74^$	5869.67 ± 1529.56^$
Hypoxia + 10% CO₂	1562.83 ± 435.32^{# &}	1185.67 ± 299.16^{# &}	7952.33 ± 1692.40^{# &}

Compared with the hypoxia + 5% CO₂ group: ^$P < 0.05, ^#P < 0.01; compared with the hypoxia + 7% CO₂ group: ^&P < 0.05.

Abbreviations: IL-1β, interleukin-1 beta; TNF-α, tumor necrosis factor alpha; IL-6, interleukin-6.

IL-1β, TNF-α, and IL-6 expression levels were negatively correlated with pH level

Expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures were significantly negatively correlated with pH levels in the medium (IL-1β: ρ = -0.735, P < 0.01; TNF-α: ρ = -0.810, P < 0.01; IL-6: ρ = -0.805, P < 0.01) (Figure 3).

Figure 3.

Expression levels of IL-1β (a), TNF-α (b), and IL-6 (c) were negatively correlated with pH levels (n = 6 per group; analyzed with Spearman’s rank correlation coefficient).

Higher levels of CO₂ treatment induced overproduction of ROS in hypoxic THP-1 cells

The fluorescence intensity of ROS in THP-1 cells was noticeably increased by exposure to hypoxia, compared with the control group (Figure 4a, b). Fluorescence in hypoxic cells was further enhanced by treatment with 7% or 10% CO₂ (Figure 4c, d). In contrast, ROS fluorescence was markedly reduced in cells that had been pretreated with NAC (Figure 4e).

Figure 4.

Higher levels of CO₂ treatment induced overproduction of ROS in hypoxic THP-1 cells (n = 4 per group). Immunofluorescence images show production of ROS (green) in hypoxic THP-1 cells. Scale bars = 20 μm. Exposures were as follows: control (20% O₂ + 5% CO₂), hypoxia + 5% CO₂ (5% CO₂ + 0.2% O₂), hypoxia + 7% CO₂ (7% CO₂ + 0.2% O₂), hypoxia + 10% CO₂ (10% CO₂ + 0.2% O₂), and hypoxia + 10% CO₂ + NAC (10% CO₂ + 0.2% O₂ + 25 mM NAC).

High levels of CO₂ exposure led to enhanced NLRP3 inflammasome activation and elevated IL-1β expression in hypoxic THP-1 cells

To explore the effects of high levels of CO₂ on NLRP3 inflammasome activation and IL-1β expression, the protein expression levels of IL-1β and caspase-1 in THP-1 cells were assessed by western blotting and double immunofluorescence. Protein expression was much higher in the hypoxia + 7% CO₂ group than in the hypoxia + 5% CO₂ group (caspase-1: P < 0.01; IL-1β: P < 0.05). The hypoxia + 10% CO₂ group had the highest levels of protein expression, compared with the hypoxia + 7% CO₂ (caspase-1: P < 0.01; IL-1β: P < 0.01) and hypoxia + 5% CO₂ groups (caspase-1: P < 0.01; IL-1β: P < 0.01). Compared with the hypoxia + 10% CO₂ group, protein expression was significantly suppressed by treatment with an ROS scavenger, 25 mM NAC (caspase-1: P < 0.01), and a pan-caspase inhibitor, 10 μM Z-YVAD-FMK (IL-1β: P < 0.01) (Figure 5a, b; Figure 6a, b).

Figure 5.

High levels of CO₂ enhanced activation of NLRP3 inflammasome in hypoxic THP-1 cells (n = 4 per group). (a) Immunoreactive bands of caspase-1 (10 kDa). (b) Relative density of caspase-1. ^*P < 0.05, ^**P < 0.01. Exposures were as follows: control (20% O₂ + 5% CO₂), hypoxia + 5% CO₂ (5% CO₂ + 0.2% O₂), hypoxia + 7% CO₂ (7% CO₂ + 0.2% O₂), hypoxia + 10% CO₂ (10% CO₂ + 0.2% O₂), and hypoxia + 10% CO₂ + NAC (10% CO₂ + 0.2% O₂ + 25 mM NAC).

Figure 6.

High levels of CO₂ increased IL-1β expression in hypoxic THP-1 cells (n = 4 per group). (a) Immunoreactive bands of IL-1β (17 kDa). (b) Relative density of IL-1β. ^*P < 0.05, ^**P < 0.01. Exposures were as follows: control (20% O₂ + 5% CO₂), hypoxia + 5% CO₂ (5% CO₂ + 0.2% O₂), hypoxia + 7% CO₂ (7% CO₂ + 0.2% O₂), hypoxia + 10% CO₂ (10% CO₂ + 0.2% O₂), and hypoxia + 10% CO₂ + Z-YVAD-FMK (10% CO₂ + 0.2% O₂ + 10 μM Z-YVAD-FMK)

Discussion

The present study showed that 7% and 10% CO₂ treatment increased expression of inflammation markers in hypoxic blood; specifically, expression levels of IL-1β, TNF-α, and IL-6 were increased in hypoxic whole blood cultures. Additionally, 7% and 10% CO₂ treatment led to enhanced activation of NLRP3 inflammasome and elevated production of IL-1β via ROS overproduction in hypoxia-activated THP-1 cells. The model of cellular hypercapnia/hypoxemia used in the present study was originally established in our previous study.¹⁶ In this model, 0.02% O₂ treatment reduced PO₂ levels in cell culture supernatant to approximately 60 mmHg. Treatment with 7% and 10% CO₂ maintained pH levels in cell culture supernatant at 7.20 to 7.30. These findings are consistent with the hypoxemia and permissive hypercapnia changes observed in patients with ARDS.^27–30

Hypercapnia has been reported to attenuate endotoxin-induced inflammation by inhibiting activation of nuclear factor-κB.^14,15 In contrast, we found that treatment with 7% and 10% CO₂ enhanced the expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures. The previous research results may appear to contradict those of the present experiments. However, during hypercapnic hypoxia, there may be differences in the underlying mechanism whereby hypercapnia exerts its effects on the blood-mediated inflammatory response. Exposure to endotoxin may induce development of inflammation through the Toll-like receptor/nuclear factor-κB pathway.^31–33 Hypoxia may activate the NLRP3 inflammasome by inducing ROS overproduction, which can lead to pyroptosis and promote a cascade of inflammatory responses.^34–37 Our previous study revealed that hypercapnia-induced NLRP3 inflammasome activation in hypoxia-activated microglia could upregulate the expression of IL-1β in a time-dependent manner—the expression of IL-1β peaked at 24 hours of exposure to hypercapnia.¹⁶ The previous findings are consistent with the effects on peripheral inflammation in hypoxic blood after 24 hours of treatment with 7% and 10% CO₂, observed in the present study.

Monocytes are reportedly the main cellular source of pro-inflammatory cytokines.^19,20 Therefore, the THP-1 human monocytic cell line was used for experiments in the present study. To explore the effects of high levels of CO₂ on NLRP3 inflammasome activation and IL-1β expression, the protein expression levels of IL-1β and caspase-1 in THP-1 cells were examined by western blotting. We found that the NLRP3 inflammasome could be activated in hypoxic THP-1 cells exposed to high levels of CO₂, as demonstrated by overproduction of ROS and upregulation of caspase-1 and IL-1β. These results suggest that high levels of CO₂ can contribute to onset of pyroptosis and promote a cascade of inflammatory responses through activation of the NLRP3 inflammasome in hypoxia-activated monocytic cells. This hypothesis was supported by the elevated expression levels of IL-1β, TNF-α, and IL-6 observed in hypoxic whole blood cultures in this study.

There were two limitations in this study. First, although 7% and 10% CO₂ treatment increased the expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures, this was an in vitro experiment. An animal experiment (such as the protocol used by Ding et al.¹⁶) should be performed to provide evidence regarding the effects of hypercapnia on inflammation in vivo. Second, it remains unclear how high levels of CO₂ treatment cause elevated expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures. Our results would be strengthened by investigation of specific pathways by which high levels of CO₂ regulate inflammation.

In summary, these preliminary findings suggest that treatment with high levels of CO₂ increases the expression levels of IL-1β, TNF-α, and IL-6 in hypoxic whole blood cultures. Permissive hypercapnia may enhance inflammation in the blood of patients with ARDS who exhibit hypoxemia.

Footnotes

Declaration of conflicting interest

The authors declare that there is no conflict of interest.

Funding

This work was supported by the Natural Science Foundation of Guangdong province (2016A030311043 and 2017A030313691), the Medical Scientific Research Foundation of Guangdong Province (A2019135), the Scientific research project of Guangdong traditional Chinese Medicine Bureau (20201045).

ORCID iD

Hongke Zeng

References

Duan

Adhikari

D’Aragon

, et al. Management of acute respiratory distress syndrome and refractory hypoxemia. A multicenter observational study. Ann Am Thorac Soc 2017; 14: 1818–1826.

Meade

Young

Hanna

, et al. Severity of hypoxemia and effect of high-frequency oscillatory ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196: 727–733.

Shen

Cai

Gong

, et al. Interaction between low tidal volume ventilation strategy and severity of acute respiratory distress syndrome: a retrospective cohort study. Crit Care 2019; 23: 254.

Fielding-Singh

Matthay

Calfee

CS.

Beyond low tidal volume ventilation: treatment adjuncts for severe respiratory failure in acute respiratory distress syndrome.

Crit Care Med 2018; 46: 1820–1831.

Brower

Matthay

Morris

, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301–1308.

Nichol

AD.

Permissive hypercapnia in acute respiratory distress syndrome - is now the time to get strict?

Crit Care Resusc 2011; 13: 142–143.

Villar

Kacmarek

Perez-Mendez

, et al. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34: 1311–1318.

Petrucci

De Feo

Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2013; 2013: D3844.

Nin

Muriel

Peñuelas

, et al. Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med 2017; 43: 200–208.

10.

Laffey

Kavanagh

BP.

Carbon dioxide and the critically ill–too little of a good thing?

Lancet 1999; 354: 1283–1286.

11.

Bein

Grasso

Moerer

, et al. The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia. Intensive Care Med 2016; 42: 699–711.

12.

Gotts

Matthay

MA.

Sepsis: pathophysiology and clinical management.

BMJ 2016; 353: i1585.

13.

Gilbert

JA.

Advancing towards precision medicine in ARDS. Lancet Respir Med 2018; 6: 494–495.

14.

Kimura

Totapally

Raszynski

, et al. The effects of CO₂ on cytokine concentrations in endotoxin-stimulated human whole blood. Crit Care Med 2008; 36: 2823–2827.

15.

Takeshita

Suzuki

Nishio

, et al. Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-kappa B activation. Am J Respir Cell Mol Biol 2003; 29: 124–132.

16.

Ding

Deng

Yang

, et al. Hypercapnia induces IL-1beta overproduction via activation of NLRP3 inflammasome: implication in cognitive impairment in hypoxemic adult rats. J Neuroinflammation 2018; 15: 4.

17.

Fann

Lee

Manzanero

, et al. Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev 2013; 12: 941–966.

18.

Dong

Yang

, et al. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway. Int J Clin Exp Pathol 2015; 8: 8731–8741.

19.

Mehta

Brewington

Chatterji

, et al. Infection-induced modulation of M1 and M2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis. Shock 2004; 22: 423–430.

20.

Spittler

Razenberger

Kupper

, et al. Relationship between interleukin-6 plasma concentration in patients with sepsis monocyte phenotype monocyte phagocytic properties and cytokine production. Clin Infect Dis 2000; 31: 1338–1342.

21.

Cao

Han

Tian

, et al. Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages. J Transl Med 2014; 12: 266.

22.

Dostert

Pétrilli

Van Bruggen

, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674–677.

23.

Pazár

Narayan

, et al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro. J Immunol 2011; 186: 2495–2502.

24.

Sun

Pokhrel

Dunphy

, et al. Reduction of acute inflammatory effects of fumed silica nanoparticles in the lung by adjusting Silanol display through calcination and metal doping. ACS Nano 2015; 9: 9357–9372.

25.

Hirota

Gold

Hiebert

, et al. The nucleotide-binding domain leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate but not adaptive immune responses after exposure to particulate matter under 10 μm. Am J Respir Cell Mol Biol 2015; 52: 96–105.

26.

O’Brien

Moehring

Muñoz-Planillo

, et al. A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. J Immunol Methods 2017; 447: 1–13.

27.

Takeuchi

Taki

Hayashi

, et al. Early application of the lung protective ventilation strategy at different stages in two ARDS patients. Masui 2004; 53: 514–521.

28.

Thorens

Jolliet

Ritz

, et al. Effects of rapid permissive hypercapnia on hemodynamics, gas exchange, and oxygen transport and consumption during mechanical ventilation for the acute respiratory distress syndrome. Intensive Care Med 1996; 22: 182–191.

29.

Hickling

Walsh

Henderson

, et al. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994; 22: 1568–1578.

30.

Dushianthan

Cusack

Chee

, et al. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians. BMC Anesthesiol 2014; 14: 87.

31.

Gay

Symmons

Gangloff

, et al. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol 2014; 14: 546–558.

32.

Chen

Liu

Langford

, et al. Haemophilus parasuis induces activation of NF-kappaB and MAP kinase signaling pathways mediated by Toll-like receptors. Mol Immunol 2015; 65: 360–366.

33.

Zhang

, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-kappaB signaling and protects against endotoxin shock. Immunity 2014; 40: 501–514.

34.

Tschopp

Schroder

NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?

Nat Rev Immunol 2010; 10: 210–215.

35.

Dai

Zhang

Xiang

, et al. Calcitriol inhibits ROS-NLRP3-IL-1beta signaling axis via activation of Nrf2-antioxidant signaling in hyperosmotic stress stimulated human corneal epithelial cells. Redox Biol 2019; 21: 101093.

36.

Hoyt

Randall

Ather

, et al. Mitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome. Redox Biol 2017; 12: 883–896.

37.

Abais

Xia

Zhang

, et al. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal 2015; 22: 1111–1129.

Treatment with 7% and 10% CO 2 enhanced expression of IL-1β,TNF-α,and IL-6 in hypoxic cultures of human whole blood

Abstract

Objective

Methods

Results

Conclusions

Keywords

Introduction

Materials and methods

Ethics and consent

Human whole blood cultures and treatment

Evaluation of IL-1β, TNF-α, and IL-6 expression levels in whole blood cultures

Human THP-1 cells: culture and treatment

Measurement of reactive oxygen species (ROS)

Western blotting

Statistical analysis

Results

PO2, PCO2, and pH levels in whole blood culture medium

Higher levels of CO2 treatment increased IL-1β, TNF-α, and IL-6 expression levels in hypoxic whole blood cultures

IL-1β, TNF-α, and IL-6 expression levels were negatively correlated with pH level

Higher levels of CO2 treatment induced overproduction of ROS in hypoxic THP-1 cells

High levels of CO2 exposure led to enhanced NLRP3 inflammasome activation and elevated IL-1β expression in hypoxic THP-1 cells

Discussion

Footnotes

Declaration of conflicting interest

Funding

ORCID iD

References

PO₂, PCO₂, and pH levels in whole blood culture medium

Higher levels of CO₂ treatment increased IL-1β, TNF-α, and IL-6 expression levels in hypoxic whole blood cultures

Higher levels of CO₂ treatment induced overproduction of ROS in hypoxic THP-1 cells

High levels of CO₂ exposure led to enhanced NLRP3 inflammasome activation and elevated IL-1β expression in hypoxic THP-1 cells